Review
Accepted on 13 Oct 2025
Unlocking New Horizons in Oncology: Ivonescimab's Dual-Target Approach to Anti-VEGF/PD-1(L1) Therapy
in Cancer Immunity and Immunotherapy
Review
Accepted on 13 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 13 Oct 2025
in Land, Livelihoods and Food Security
Original Research
Accepted on 13 Oct 2025
in Inflammation
Original Research
Accepted on 13 Oct 2025
in Addictive Disorders
Original Research
Accepted on 13 Oct 2025
in Pediatric Cardiology
Original Research
Accepted on 13 Oct 2025
in Inflammation
Original Research
Accepted on 13 Oct 2025
in Pediatric Cardiology
Mini Review
Accepted on 13 Oct 2025
in Marine Biotechnology and Bioproducts
Original Research
Accepted on 13 Oct 2025
in Healthcare Professions Education
Original Research
Accepted on 13 Oct 2025
in Organizational Communication
Original Research
Accepted on 13 Oct 2025
in Inflammation
Original Research
Accepted on 13 Oct 2025
in Organizational Communication
Perspective
Accepted on 13 Oct 2025
in Regulatory Science
Original Research
Accepted on 13 Oct 2025
in Brain Health and Clinical Neuroscience
Original Research
Accepted on 13 Oct 2025
in Technical Advances in Plant Science
Original Research
Accepted on 13 Oct 2025
in Cellular Neurophysiology